![Per Richard Torbjörn Hallberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Per Richard Torbjörn Hallberg
Director/Board Member at
DOVA PHARMACEUTICALS, INC.
Net worth: 4 M $ as of 2026-07-30
Profile
Per Richard Torbjörn Hallberg is currently Director at Takeda Oy since 2016, Director at Dova Pharmaceuticals, Inc. since 2019, Director at Swedish Orphan Biovitrum, Inc., Director at Swedish Orphan Biovitrum (Belgium) SARL since 2021, and General Counsel & Head-Legal Affairs at Swedish Orphan Biovitrum AB since 2018.
Former roles include Senior Associate at Advokatfirman Lindahl KB from 1997 to 2001, Corporate Counsel at Ferring Pharmaceuticals, Inc. from 2001 to 2004, Corporate Counsel at Nycomed AB from 2004 to 2010, and Vice President & General Counsel-Emerging Markets at Takeda AB from 2015 to 2017.
Education includes graduate studies at the University of Lund.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-11 | 78,949 ( 0.02% ) | 4 M $ | 2026-07-30 |
Per Richard Torbjörn Hallberg active positions
| Companies | Position | Start |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | General Counsel | 2017-12-31 |
| DOVA PHARMACEUTICALS, INC. | Director/Board Member | 2019-11-11 |
Takeda Oy
 Takeda Oy Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 2016-04-30 |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Director/Board Member | - |
Swedish Orphan Biovitrum (Belgium) SARL
 Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Engages in development of treatment for diseases | Director/Board Member | 2021-05-31 |
Former positions of Per Richard Torbjörn Hallberg
| Companies | Position | End |
|---|---|---|
Takeda AB | Director/Board Member | 2016-12-31 |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | General Counsel | 2009-12-31 |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | General Counsel | 2003-12-31 |
Advokatfirman Lindahl KB
 Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 2000-12-31 |
Training of Per Richard Torbjörn Hallberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Advokatfirman Lindahl KB
Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Takeda AB | |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Engages in development of treatment for diseases | Health Technology |
- Stock Market
- Insiders
- Per Richard Torbjörn Hallberg
